Nanosphere Announces Reverse Split of Common Stock
April 07, 2015 11:55 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., April 7, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, announced today that a 20-to-1 reverse split of...
Scripps Study Illustrates Clinical and Economic Impact of Verigene BC-GP Rapid Blood Culture Test With Antibiotic Stewardship Intervention
March 25, 2015 08:00 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., March 25, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, and Scripps Health, a private, nonprofit,...
Verigene System Positioned to Provide Rapid Diagnosis of Outbreaks of CRE "Superbugs"
March 12, 2015 16:01 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., March 12, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, offers the Verigene® Gram-Negative Blood...
Nanosphere Announces Special Meeting of Stockholders and Filing of Definitive Proxy Statement With SEC
March 03, 2015 17:00 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., March 3, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that it will conduct a special...
Nanosphere Announces Fourth Quarter and Full Year 2014 Results, 2015 Guidance and Next Generation Verigene Progress
February 11, 2015 16:01 ET
|
Nanosphere, Inc.
Corporate Highlights and Guidance:
Record fourth quarter and fiscal year revenues of $4.6 million, and $14.3 million, respectively
47 new customer placements in the fourth...
Nanosphere to Release Fourth Quarter & Fiscal Year 2014 Results and Host Investor Conference Call on Wednesday, February 11
February 09, 2015 10:07 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Feb. 9, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that it will report its results...
Nanosphere Announces Fourth Quarter and Full Year 2014 Preliminary Top Line Results, Director and Management Changes and Receipt of FDA Warning Letter
January 28, 2015 16:00 ET
|
Nanosphere, Inc.
Corporate Highlights:
Record fourth quarter and fiscal year preliminary revenue of $4.6 million and $14.3 million, respectively
47 new customer placements in fourth quarter
Roger Moody...
Nanosphere to Release Preliminary Fourth Quarter & Fiscal Year 2014 Results and Host Investor Conference Call on Wednesday, January 28
January 26, 2015 17:14 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Jan. 26, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that it will report preliminary...
Nanosphere Announces Third Quarter Financial and Operating Results
November 05, 2014 16:01 ET
|
Nanosphere, Inc.
Corporate Highlights and Business Guidance:
Q3 2014 revenues of $3.7 million, a 56% increase over Q3 2013, and 30 new customer placements.
Received FDA clearance of Verigene®...
Nanosphere to Release Third Quarter Results and Host Investor Conference Call on Wednesday, November 5
October 28, 2014 16:01 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Oct. 28, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that it will report its results...